动态疗法 (PDT) 市场规模、份额、成长分析（按机制、类别、治疗方法、软体、服务、应用程式可访问性、应用和地区）- 产业预测，2025 年至 2032 年

全球动态疗法 (PDT) 市场规模预计在 2023 年达到 41 亿美元，从 2024 年的 49.3 亿美元增长到 2032 年的 216.4 亿美元，预测期内（2025-2032 年）的复合年增长率为 20.3%。

全球调查方法越来越受到对超越传统方法的个人化、疗效驱动型治疗解决方案需求的影响。这种转变源于人们日益认识到，客製化治疗方案可提高患者参与度和临床疗效，从而最大限度地减少对传统药理学方法的依赖。由于监管机构建立了更清晰的核准途径，因此光动力治疗 (PDT) 被越来越广泛地纳入标准治疗方案中。此外，越来越多的保险公司认识到 PDT 在管理慢性病和行为健康状况方面的价值，从而推动了科技公司、医疗保健提供者和生命科学公司之间的合作。主要趋势包括注重临床检验、数位健康创新者与成熟医疗保健营业单位之间的伙伴关係，以及解决对资料隐私和安全的关键担忧，以确保提供稳健的、以患者为中心的治疗。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与约束

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术分析
• 案例研究
• 顾客购买行为分析

动态疗法 (PDT) 市场规模（按机制和复合年增长率） (2025-2032)

• 市场概览
• 输入机制
• 输出机制

动态疗法 (PDT) 市场规模（按类别）及复合年增长率（2025-2032）

• 市场概览
• 药物增强
• 药物替代

动态疗法 (PDT) 市场规模：依治疗方法和复合年增长率（2025-2032 年）

• 市场概览
• 门诊治疗
• 单药治疗

动态疗法 (PDT) 市场规模（按软体和复合年增长率） (2025-2032)

• 市场概览
• 呼吸疾病软体
• 心理健康软体
• 阿片类药物使用疾患软体
• 糖尿病软体
• 其他的

动态疗法 (PDT) 市场规模（按服务类型和复合年增长率） (2025-2032)

• 市场概览
• 行为微服务
• 医疗微服务

动态疗法 (PDT) 市场规模（按应用可近性及复合年增长率）(2025-2032)

• 市场概览
• Android
• iOS
• Windows

动态疗法 (PDT) 市场规模（按应用类型和复合年增长率）（2025-2032）

• 市场概览
• 原生应用
• Web 应用程式

动态疗法（PDT）市场规模：按应用和复合年增长率（2025-2032）

• 市场概览
• 物质使用疾患（SUD）
• 阿片类药物使用疾患（OUD）
• 注意力不足过动症（ADHD）
• 阿兹海默症
• 重度忧郁症（MDD）
• 失眠
• 癫痫
• 运动障碍
• 多发性硬化症
• 偏头痛
• 泛自闭症障碍
• 肿瘤学
• 发炎
• 呼吸系统
• 心血管系统
• 疼痛管理
• 代谢状态
• 其他的

动态疗法（PDT）市场规模：依病患分类及复合年增长率（2025-2032）

• 市场概览
• 孩子
• 成人

动态疗法（PDT）市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 按部门分類的公司份额分析
  • 收益同比对比（2022-2024 年）

主要企业简介

• ResMed（US）
• SAMSUNGHEALTHCARE（South Korea）
• Novartis AG（Switzerland）
• Medtronic（Ireland）
• Omada Health, Inc.（US）
• GAIA AG（Germany）
• Welldoc's Bluestar（US）
• Better Therapeutics, LLC（US）
• BigHealth（US）
• Biofourmis（US）
• Click Therapeutics, Inc.（US）
• Happify, Inc.（US）
• Naturalcycles Nordic AB（Sweden）
• NuvoAir AB（Sweden）
• Sensyne Health plc.（UK）

结论和建议

Global Photodynamic Therapy (PDT) Market size was valued at USD 4.1 billion in 2023 and is poised to grow from USD 4.93 billion in 2024 to USD 21.64 billion by 2032, growing at a CAGR of 20.3% during the forecast period (2025-2032).

The global Photodynamic Therapy (PDT) landscape is increasingly influenced by the demand for personalized and efficacy-driven treatment solutions that transcend conventional methodologies. This shift stems from a growing acknowledgment that customized therapeutic programs enhance patient engagement and clinical results, minimizing dependence on traditional pharmacological approaches. Integration of PDT into standard care routines is becoming prevalent, facilitated by clearer approval pathways established by regulatory agencies. Additionally, insurance providers are increasingly recognizing the value of PDT in managing both chronic and behavioral health conditions, driving collaborative efforts among tech companies, healthcare providers, and life-science firms. Key trends include a focus on clinical validation and partnerships between digital health innovators and established healthcare entities, addressing critical concerns around data privacy and security to ensure robust, patient-focused therapies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Photodynamic Therapy (PDT) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Photodynamic Therapy (PDT) Market Segments Analysis

Global Photodynamic Therapy (PDT) Market is segmented by Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients and region. Based on Mechanism, the market is segmented into Input Mechanisms and Output Mechanisms. Based on Category, the market is segmented into Medication Augmentation and Medication Replacement. Based on Treatment, the market is segmented into Outpatient Treatment and Monotherapy. Based on Software, the market is segmented into Software for Respiratory Conditions, Software for Mental Health, Software for Opioid Use Disorder, Software for Diabetes and Others. Based on Services, the market is segmented into Behavioral Microservices and Medical Microservices. Based on App Accessibility, the market is segmented into Android, iOS and Windows. Based on App Type, the market is segmented into Native Apps and Web Apps. Based on Application, the market is segmented into Substance Use Disorder (SUD), Opioid Use Disorder (OUD), Attention Deficit/Hyperactivity Disorder (ADHD), Alzheimer's Disease, Major Depressive Disorder (MDD), Insomnia, Epilepsy, Movement Disorder, Multiple Sclerosis, Migraine, Autism Spectrum Disorder, Oncology, Inflammation, Respiratory, Cardiovascular, Pain Management, Metabolic Conditions and Others. Based on Patients, the market is segmented into Children and Adults. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Photodynamic Therapy (PDT) Market

The increasing focus on patient-centric care is significantly driving growth in the global Photodynamic Therapy (PDT) market. There is a heightened demand for therapeutic solutions that prioritize personalized support rather than relying solely on traditional medications. Prescription digital therapeutics are gaining traction, offering structured and evidence-based programs that can be tailored to the unique requirements of each patient. This evolution is particularly essential for the management of chronic and behavioral health issues, where ongoing engagement and real-time feedback play a crucial role. As patients' expectations shift, the attractiveness of customized, technology-driven treatment options continues to expand.

Restraints in the Global Photodynamic Therapy (PDT) Market

Despite the increasing interest in photodynamic therapy (PDT), there is still a significant lack of awareness among healthcare providers and patients regarding its clinical benefits and accessibility. This unfamiliarity contributes to reluctance in adopting PDT, resulting in lower prescription rates. Furthermore, the available training and educational resources are insufficient, hindering the integration of PDT into standard treatment practices. Without a deeper understanding among key stakeholders, the market potential for PDT remains largely untapped, as misconceptions and a lack of knowledge impede its acceptance and implementation in therapeutic settings.

Market Trends of the Global Photodynamic Therapy (PDT) Market

The Global Photodynamic Therapy (PDT) market is experiencing a transformative trend driven by the integration of drug-digital combination therapies. Pharmaceutical companies are forging partnerships with digital therapeutic developers to create innovative solutions that combine PDT with software-based interventions. This synergistic approach enhances treatment efficacy by modifying both patient behavior and pharmacological responses simultaneously. The incorporation of digital tools not only aids in adherence tracking but also facilitates the collection of real-world data, leading to improved therapeutic outcomes. As the demand for personalized medicine and enhanced patient care continues to rise, the PDT market is poised for significant growth, characterized by this collaborative evolution.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Photodynamic Therapy (PDT) Market Size by Mechanism & CAGR (2025-2032)

• Market Overview
• Input Mechanisms
• Output Mechanisms

Global Photodynamic Therapy (PDT) Market Size by Category & CAGR (2025-2032)

• Market Overview
• Medication Augmentation
• Medication Replacement

Global Photodynamic Therapy (PDT) Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Outpatient Treatment
• Monotherapy

Global Photodynamic Therapy (PDT) Market Size by Software & CAGR (2025-2032)

• Market Overview
• Software for Respiratory Conditions
• Software for Mental Health
• Software for Opioid Use Disorder
• Software for Diabetes
• Others

Global Photodynamic Therapy (PDT) Market Size by Services & CAGR (2025-2032)

• Market Overview
• Behavioral Microservices
• Medical Microservices

Global Photodynamic Therapy (PDT) Market Size by App Accessibility & CAGR (2025-2032)

• Market Overview
• Android
• iOS
• Windows

Global Photodynamic Therapy (PDT) Market Size by App Type & CAGR (2025-2032)

• Market Overview
• Native Apps
• Web Apps

Global Photodynamic Therapy (PDT) Market Size by Application & CAGR (2025-2032)

• Market Overview
• Substance Use Disorder (SUD)
• Opioid Use Disorder (OUD)
• Attention Deficit/Hyperactivity Disorder (ADHD)
• Alzheimer's Disease
• Major Depressive Disorder (MDD)
• Insomnia
• Epilepsy
• Movement Disorder
• Multiple Sclerosis
• Migraine
• Autism Spectrum Disorder
• Oncology
• Inflammation
• Respiratory
• Cardiovascular
• Pain Management
• Metabolic Conditions
• Others

Global Photodynamic Therapy (PDT) Market Size by Patients & CAGR (2025-2032)

• Market Overview
• Children
• Adults

Global Photodynamic Therapy (PDT) Market Size & CAGR (2025-2032)

• North America (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • US
  • Canada
• Europe (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Mechanism, Category, Treatment, Software, Services, App Accessibility, App Type, Application, Patients)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• ResMed (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SAMSUNGHEALTHCARE (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omada Health, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GAIA AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Welldoc's Bluestar (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Better Therapeutics, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BigHealth (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biofourmis (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Click Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Happify, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Naturalcycles Nordic AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuvoAir AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sensyne Health plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations